Palbociclib breast cancer drug capsule. This drug, marketed as Ibrance, is a kinase inhibitor. It acts on cyclin-dependent kinases 4 and 6, which regulate the cell cycle. Blocking their action prevents cell division and the growth of the cancer. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Marazzi, Dr. P. |
Bildgröße: | 5520 px × 3680 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: |
|